Xiaonan Hou Selected Research

Xiaonan Hou Research Topics

Disease

36	Neoplasms (Cancer) 07/2022 - 11/2006
25	Ovarian Neoplasms (Ovarian Cancer) 07/2022 - 09/2008
9	Breast Neoplasms (Breast Cancer) 01/2021 - 09/2008
6	Neoplasm Metastasis (Metastasis) 01/2022 - 03/2012
5	Carcinoma (Carcinomatosis) 01/2022 - 11/2016
5	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 12/2017
2	Endometrial Neoplasms (Endometrial Cancer) 10/2020 - 11/2006
2	Carcinogenesis 01/2016 - 12/2013
1	Hematologic Neoplasms (Hematological Malignancy) 01/2021
1	Chemotherapy-Related Cognitive Impairment 01/2021
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2021
1	Melanoma (Melanoma, Malignant) 01/2021
1	Multiple Myeloma 01/2021
1	Neuroblastoma 01/2021
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2021
1	Cognitive Dysfunction 01/2021
1	Ascites 08/2018
1	Hyperlipidemias (Hyperlipidemia) 01/2018
1	Atherosclerosis 01/2018
1	Frailty 01/2018

Drug/Important Bio-Agent (IBA)

7	PlatinumIBA 07/2022 - 01/2017
7	Proteins (Proteins, Gene)FDA Link 09/2021 - 11/2006
6	Pharmaceutical PreparationsIBA 07/2022 - 01/2011
6	Paclitaxel (Taxol)FDA LinkGeneric 12/2021 - 11/2006
5	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022 - 01/2015
5	Letrozole (Femara)FDA LinkGeneric 10/2020 - 12/2011
4	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2019
3	niraparibIBA 09/2021 - 11/2016
3	Estrogen ReceptorsIBA 01/2021 - 01/2017
3	Tamoxifen FDA LinkGeneric 01/2020 - 12/2011
3	Carboplatin (JM8)FDA LinkGeneric 11/2016 - 11/2006
3	Insulin-Like PeptidesIBA 10/2016 - 01/2011
2	olaparibIBA 01/2022 - 01/2020
2	S63845IBA 12/2021 - 10/2021
2	rucaparibIBA 09/2021 - 01/2020
2	Androgen Receptors (Androgen Receptor)IBA 01/2021 - 01/2018
2	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 01/2016
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2020 - 11/2016
2	4-hydroxy-N-desmethyltamoxifenIBA 01/2020 - 12/2014
2	Aromatase InhibitorsIBA 01/2020 - 10/2016
2	Everolimus FDA Link 01/2020 - 01/2017
2	Messenger RNA (mRNA)IBA 10/2019 - 01/2019
2	Transcription Factors (Transcription Factor)IBA 12/2017 - 01/2016
2	Hormones (Hormone)IBA 10/2016 - 12/2011
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2015 - 12/2013
2	Insulin ReceptorIBA 01/2011 - 09/2008
2	BMS 536924IBA 01/2011 - 09/2008
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2022
1	IntegrinsIBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	Immunoconjugates (Immunoconjugate)IBA 01/2022
1	ceritinibIBA 01/2022
1	Platinum Compounds (Compounds, Platinum)IBA 12/2021
1	taxaneIBA 11/2021
1	Deubiquitinating EnzymesIBA 11/2021
1	Taxoids (Taxanes)IBA 11/2021
1	choline salicylateIBA 01/2021
1	selinexorIBA 01/2021
1	N-Myc Proto-Oncogene ProteinIBA 01/2021
1	Docetaxel (Taxotere)FDA Link 01/2021
1	Azacitidine (5 Azacytidine)FDA Link 01/2021
1	CamptothecinIBA 01/2021
1	InterferonsIBA 01/2021
1	Nicotinamide MononucleotideIBA 01/2021
1	Phenobarbital (Luminal)FDA Link 01/2021
1	SalicylatesIBA 01/2021
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2021
1	ribociclibIBA 10/2020
1	matrigelIBA 01/2020
1	Oncogene Proteins (Oncogene Protein)IBA 01/2020
1	talazoparibIBA 01/2020
1	Fulvestrant (Faslodex)FDA Link 01/2020
1	Poly Adenosine Diphosphate RiboseIBA 01/2020
1	exemestane (Aromasin)FDA Link 01/2020
1	Cytosine DeaminaseIBA 01/2020
1	VLX600IBA 12/2019
1	N-nitroso-N-methyltyramine (NNMT)IBA 12/2019
1	WZB117IBA 12/2019
1	Glucose (Dextrose)FDA LinkGeneric 12/2019
1	Adenosine Triphosphate (ATP)IBA 12/2019
1	Tigecycline (Tygacil)FDA Link 12/2019
1	Monoclonal AntibodiesIBA 01/2019
1	Antisense OligonucleotidesIBA 01/2019
1	MethyltransferasesIBA 01/2019
1	Pregnancy-Associated Plasma Protein-A (PAPP-A)IBA 01/2019
1	Protein Kinases (Protein Kinase)IBA 01/2019
1	Immunoglobulin G (IgG)IBA 01/2019
1	Collagen Type XIIBA 08/2018
1	Versicans (Versican)IBA 08/2018
1	Transforming Growth Factor beta (TGF-beta)IBA 08/2018
1	LY-2157299IBA 08/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	QuercetinIBA 01/2018
1	RGFP966IBA 01/2018
1	ElementsIBA 01/2018
1	CytokinesIBA 01/2018

Therapy/Procedure

16	Therapeutics 07/2022 - 09/2008
8	Drug Therapy (Chemotherapy) 11/2021 - 11/2006
1	Immunotherapy 01/2021
1	Lab-On-A-Chip Devices 01/2020